Related Experiment Video
Updated: Jul 30, 2026

Detection of Live Escherichia coli O157:H7 Cells by PMA-qPCR
Published on: February 1, 2014
Detection of Cryptosporidium parvum in human feces by PCR
P Fischer1, H Taraschewski, R Ringelmann
1Institut fuer Medizinische Mikrobiologie und Immunologie, Staedt, Klinikum Karlsruhe, Germany.
Abstract:
C. parvum has a high pathologic potential also for man, especially for immununosuppressed patients. The microscopic detection of cysts in feces is neither easy nor always reliable. During the recent years, considerable progress has been achieved in establishing PCR-based approaches for i) sensitive detection of C. parvum in a variety of specimen types [3, 9-16, 18, 21, 24, 25, 27, 29-32, 34], ii) identification of individual genotypes of C. parvum [2, 4-7, 17, 19, 20, 22, 23, 26, 28, 33] and iii) viability testing of C. parvum organisms [8, 9, 13, 29, 30]. The protocols published so far include nested PCR [3, 8, 18, 34], RT-PCR [13, 29], and use of the UNG carryover prevention system [10]. The aim of this work was to establish a PCR system for the detection of C. parvum oocysts in stool samples, applying the same specimen preparation procedure as applied for immunofluorescence. In addition, we combined the UNG carryover prevention system with the use of long, PCR-generated digoxigenin-labelled probes, thus achieving a sensitivity comparable to nested PCR und circumventing the contamination risks associated with nested PCR protocols. We developed a simplified sucrose-cushion-based protocol for preparation of clinical specimens (adopted from [1]), satisfying both the needs of immunofluorescence and PCR. When tested with stool samples spiked with C. parvum oocysts, the analytical sensitivity of PCR was 3,500 oocysts/ml stool (immunofluorescence: 3,000 oocysts/ml stool), demonstrating that both methods were equivalent with respect to analytical sensitivity. However, when PCR and immnunofluorescence were applied to clinical samples (n=5) with known positivity for C. parvum, only the specimen with the shortest duration of storage (5 weeks) could be correctly identified by PCR (clinical sensitivity: 20%). Our results demonstrate, that the PCR approach presented in this work is not suited for highly sensitive detection of C. parvum in faeces. This was mainly due to the fact that sucrose-gradient purified material was used, which relies on the presence of morphologically intact oocysts in the specimens. Desintegration of oocysts by excystation and/or storage may lower the parasite yield of the protocol drastically. As a consequence, a protocol extracting the entire DNA from faeces should be used for PCR for detection of C. parvum [34].
Insights
A new PCR method for Cryptosporidium parvum (C. parvum) detection in stool samples showed high analytical sensitivity but low clinical sensitivity. This PCR approach is not ideal for detecting C. parvum in feces due to issues with oocyst integrity.
Area of Science:
- Medical Parasitology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Cryptosporidium parvum (C. parvum) poses a significant health risk, particularly to immunocompromised individuals.
- Microscopic detection of C. parvum cysts in feces is challenging and unreliable.
- PCR-based methods have advanced C. parvum detection, genotyping, and viability testing.
Purpose of the Study:
- To develop a PCR system for detecting C. parvum oocysts in stool samples.
- To integrate a UNG carryover prevention system with long, digoxigenin-labeled probes for enhanced sensitivity and reduced contamination risk.
- To utilize a specimen preparation protocol compatible with both immunofluorescence and PCR.
Main Methods:
- Developed a simplified sucrose-cushion-based protocol for clinical specimen preparation.
- Combined UNG carryover prevention with long, PCR-generated digoxigenin-labeled probes.
- Compared analytical and clinical sensitivity of the developed PCR method against immunofluorescence using spiked and clinical stool samples.
Main Results:
- The PCR method achieved an analytical sensitivity of 3,500 C. parvum oocysts/ml stool, comparable to immunofluorescence (3,000 oocysts/ml).
- Clinical sensitivity was low (20%), with only one of five positive samples correctly identified, particularly the one with the shortest storage duration.
- The sucrose-gradient purification method, reliant on intact oocysts, significantly reduced parasite yield in clinical samples.
Conclusions:
- The developed PCR method, using sucrose-gradient purification, is not suitable for highly sensitive C. parvum detection in feces.
- Oocyst disintegration due to excystation or prolonged storage drastically impacts parasite yield, limiting PCR effectiveness.
- For reliable C. parvum detection via PCR, protocols that extract total DNA directly from feces are recommended.
More Related Videos
08:37Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
12:14A Duplex Digital PCR Assay for Simultaneous Quantification of the Enterococcus spp. and the Human Fecal-associated HF183 Marker in Waters
Published on: March 9, 2016